You must be logged in and verified to contact the designer.
Product Description
3D print of Victoza. Model created from PDB ID: 4APD. Model Description
This is a 3D print of GLP-1 Analog (Victoza) in Complex with GLP-1 Receptor and visualized as a volumetric surface. Protein Description Liraglutide (NN2211) is a long-acting glucagon-like peptide-1 receptor agonist, binding to the same receptors as does the endogenousmetabolichormoneGLP-1 that stimulates insulin secretion. Marketed under the brand name Victoza, it is an injectable drug developed by Novo Nordisk for the treatment of type 2 diabetes. In 2015, Novo Nordisk began marketing it in the U.S. under the brand name Saxenda as a treatment forobesity in adults with at least one weight-related comorbid condition.